This drug delivery program is DNA-based.

The DNase, an enzyme that could break up the DNA cocoon normally, is covered in a slim polymer that traps the DNase such as a sword in a sheath. The top of nano-cocoon is usually studded with folic acid ligands. When the nano-cocoon encounters a cancer tumor cell, the ligands bind the nano-cocoon to receptors on the top of cell – leading to the cell to suck in the nano-cocoon. Once in the tumor cell, the cell’s acidic environment destroys the polymer sheath comprising the DNase.Related StoriesStem cell study to help fight congenital brittle bone diseaseNYSCF meeting to spotlight translational stem cell and neuroscience researchLight-chain amyloidosis individuals treated with high-dosage chemo and stem cell transplantation possess long-term survival The Orphan Medication Designation was granted for usage of BL-8040, in conjunction with granulocyte colony-stimulating aspect , to mobilize individual stem cells from the bone marrow to the peripheral bloodstream for collection for autologous or allogeneic transplantation.